Literature DB >> 3961840

Characterization of muscarinic cholinergic receptors in human and dog cerebral arteries.

T Tsukahara, H Usui, T Taniguchi, S Shimohama, M Fujiwara, H Handa.   

Abstract

Various concentrations of acetylcholine (ACh) produced dose dependent relaxations of isolated, helical preparations of human cerebral arteries and these responses were blocked by atropine. The median effective concentration (EC50) of ACh was 6.1 +/- 0.2 X 10(-6)M. ACh produced dual responses in isolated dog cerebral arteries. ACh in low concentrations produced relaxation, and contraction occurred when the concentration was raised to 1 X 10(-5)M. The EC50 of ACh which produced relaxation, in dog cerebral arteries was 7.2 +/- 0.2 X 10(-7)M. Muscarinic cholinergic receptors in these arteries were analyzed directly using 3H-QNB as the ligand. The specific 3H-QNB binding to the arteries was saturable and of KD = 1.5 nM and Bmax = 93 fmol/mg protein in human cerebral arteries and KD = 0.59 nM, Bmax = 340 fmol/mg protein in dog cerebral arteries. Specific binding of 3H-QNB was displaced by muscarinic cholinergic agents. Ki values and Hill coefficients were as follows: QNB, 1.0 X 10(-9)M, 0.89; atropine, 1.1 X 10(-8)M, 0.95; ACh, 0.8 X 10(-8)M and 2.1 X 10(-6)M, 0.54; carbachol, 1.2 X 10(-7)M and 4.3 X 10(-5)M, 0.33 in human cerebral arteries and QNB, 0.55 X 10(-9)M, 0.85; atropine 0.9 X 10(-9)M, 1.00; ACh, 0.9 X 10(-9)M and 1.1 X 10(-6)M, 0.43; carbachol 6.3 X 10(-8)M and 1.1 X 10(-5)M, 0.36 in dog cerebral arteries. Endogenous choline acetyltransferase (ChAT) activity was 1.6 +/- 0.4 nmol/mg protein/hr in human cerebral arteries and 3.7 +/- 0.1 nmol/mg protein/hr in dog cerebral arteries.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3961840     DOI: 10.1161/01.str.17.2.300

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

Review 1.  Parasympathetic innervation of vertebrobasilar arteries: is this a potential clinical target?

Authors:  Eva V L Roloff; Ana M Tomiak-Baquero; Sergey Kasparov; Julian F R Paton
Journal:  J Physiol       Date:  2016-10-05       Impact factor: 5.182

2.  Comparison of the muscarinic receptors in the coronary artery, cerebral artery and atrium of the pig.

Authors:  K J van Charldorp; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

3.  Pharmacological characterization of muscarinic acetylcholine binding sites in human and bovine cerebral microvessels.

Authors:  D G Linville; E Hamel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

4.  Contractile and relaxant responses of the canine isolated spinal artery to vasoactive substances.

Authors:  K Shirai; Y Kawai; T Ohhashi
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

5.  Glycopyrrolate does not influence the visual or motor-induced increase in regional cerebral perfusion.

Authors:  Kim Z Rokamp; Niels D Olesen; Henrik B W Larsson; Adam E Hansen; Thomas Seifert; Henning B Nielsen; Niels H Secher; Egill Rostrup
Journal:  Front Physiol       Date:  2014-02-11       Impact factor: 4.566

6.  Vagolytic atropine attenuates cerebral vasodilation response during acute orthostatic hypotension.

Authors:  Woo-Jong Choi; Kichang Lee; Young-Kug Kim; Kyo-Joon Song; Sung-Moon Jeong; Gyu-Sam Hwang
Journal:  Korean J Anesthesiol       Date:  2015-11-25

7.  Long-acting Inhaled Bronchodilator and Risk of Vascular Events in Patients With Chronic Obstructive Pulmonary Disease in Taiwan Population.

Authors:  Ming-Jun Tsai; Chung-Yu Chen; Yaw-Bin Huang; Hsiao-Chung Chao; Chih-Jen Yang; Pei-Chin Lin; Yi-Hung Tsai
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.